- Home
- ASRT vs ICCM Comparison
ASRT vs ICCM Comparison
Compare ASRT & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- ICCM
- Stock Information
- Founded
- ASRT 1995
- ICCM 2006
- Country
- ASRT United States
- ICCM Israel
- Employees
- ASRT N/A
- ICCM N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- ICCM
- Sector
- ASRT Health Care
- ICCM
- Exchange
- ASRT Nasdaq
- ICCM Nasdaq
- Market Cap
- ASRT 57.9M
- ICCM 59.5M
- IPO Year
- ASRT 1997
- ICCM N/A
- Fundamental
- Price
- ASRT $0.65
- ICCM $0.95
- Analyst Decision
- ASRT Strong Buy
- ICCM Strong Buy
- Analyst Count
- ASRT 2
- ICCM 1
- Target Price
- ASRT $3.25
- ICCM $2.50
- AVG Volume (30 Days)
- ASRT 207.4K
- ICCM 221.0K
- Earning Date
- ASRT 08-06-2025
- ICCM 08-19-2025
- Dividend Yield
- ASRT N/A
- ICCM N/A
- EPS Growth
- ASRT N/A
- ICCM N/A
- EPS
- ASRT N/A
- ICCM N/A
- Revenue
- ASRT $119,001,000.00
- ICCM $3,273,000.00
- Revenue This Year
- ASRT N/A
- ICCM $83.41
- Revenue Next Year
- ASRT $11.91
- ICCM $185.02
- P/E Ratio
- ASRT N/A
- ICCM N/A
- Revenue Growth
- ASRT N/A
- ICCM 0.34
- 52 Week Low
- ASRT $0.51
- ICCM $0.48
- 52 Week High
- ASRT $1.80
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- ASRT 49.30
- ICCM 37.48
- Support Level
- ASRT $0.60
- ICCM $0.98
- Resistance Level
- ASRT $0.68
- ICCM $1.00
- Average True Range (ATR)
- ASRT 0.03
- ICCM 0.04
- MACD
- ASRT -0.00
- ICCM -0.00
- Stochastic Oscillator
- ASRT 67.00
- ICCM 6.46
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.